🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The Rise of Single-Specialty Hospitals | We are seeing significant localisation in specific segments such as hair, #skincare, and dental, says Anshul Gupta, MD & Head of Healthcare Investment, Avendus Capital. Tells Ekta Batra & Mangalam Maloo that #eyecare is among the segments

Diabetes market in India heating up !

Amazon's Diagnostics Entry | #Diagnostics stocks are under pressure as #Amazon has announced its entry into the sector with the launch of an at home diagnostics service in partnership with #OrangeHealth Amazon India Ekta Batra

#NovoNordisk launches blockbuster weight loss drug Wegovy in India Ekta Batra cnbctv18.com/business/compa…

Wegovy launches in India. Listen into an exclusive conversation with Novo Nordisk on pricing, competition, efficacy and side effects

#CNBCTV18Exclusive | Launching 5 strengths of #Wegovy (Weight loss drug) in the #Indian market: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg. Wegovy 0.25, 0.5 and 1 mg injection is priced at ₹17,345/month. Will assess accessibility & pricing points for Wegovy once competition

CNBC-TV18 Exclusive | We are confident of leading the weight loss #market as we are first to launch and have strong credibility, says Vikrant Shrotriya, MD & Corporate VP, Novo Nordisk India, as the company launches #Wegovy, a weight loss drug, in #India. Tells Ekta Batra that 1

Novo Nordisk Weight Loss Drug | 'Whenever there is a prescription, it should be under the doctor’s supervision' Semaglutide has become a go-to medication for weight loss and managing obesity—but what about the side effects, and what happens if you stop taking it? Ekta Batra

"Orange Health & Amazon is a truly organic partnership," says Jayaramakrishnan Balasubramanian, Director-Medical at Amazon India. In a conversation with Ekta Batra, he discusses how this collaboration aims to deliver the right healthcare experience to customers, blending

New weight loss treatments are here—but are they right for you? Ask us anything about obesity, Mounjaro, or Wegovy. We will have our experts answer them on #TheMedicineBox #CNBCTV18 Ekta Batra Drop your questions in the comments below👇

Key highlights from my chat with Novo Nordisk on launch of blockbuster weight-loss drug Wegovy in India Priced ₹17K–₹26K/month No near-term plans to launch Ozempic in India Launch after Mounjaro "incidental" #Wegovy #NovoNordisk #GLP1 #Mounjaro CNBC-TV18 Shereen Bhan

Novo Nordisk launches blockbuster weight-loss drug Wegovy in India. Listen in to the debate on side effects No causal link to eye complications Muscle loss expected; thyroid issues seen only in animals Stopping Wegovy may lead to weight regain CNBC-TV18

India’s growing obesity burden and the rise of powerful new weight loss drugs Ekta Batra cnbctv18.com/india/healthca…

Don’t miss this! Weight loss drugs now in India — Mounjaro and Wegovy. What do they mean for India’s obesity crisis? Top experts Dr. Ambrish Mithal (Max Healthcare) and Dr. Sonali Kagne (Sir H. N. Reliance Foundation Hospital) join us to break it down youtu.be/_kvznsPStY8?si…

Mega Pharma Deal | #TorrentPharma announces a two-phase #acquisition of #JBChemicals from #KKR, one of the largest deals in India’s branded pharma space since the Ranbaxy-Sun merger. What are the contours of the #deal, its impact on both #businesses, and what are brokerages

Torrent Pharma is set to acquire JB Chemicals from KKR at ₹25,689 cr valuation executed in two phases. What does this acquisition mean for the company? Ekta Batra explains #TorrentPharma #JBChemicals #Acquisition #Pharmacy #CNBCTV18Digital

The IV wellness market is booming. From vitamin to beauty drips. But what are the risks ? And how is the master antioxidant glutathione being misused ? All this on The Medicine Box. Stay informed. Shereen Bhan CNBC-TV18 youtu.be/sIlO80P1rzw

When we started #TheMedicineBox 2 years ago, I was asked why is a “business” channel covering health! Our DNA has always been about providing actionable, verifiable information to our viewers and health is the biggest investment we can make! Here is our latest on the current rage

Thank you Kiran Mazumdar-Shaw

The Indian pharma market grew 8% in June 2025, led by strong performances from Sun Pharma, Glenmark, Ipca Labs, JB Chemicals & more. Alkem’s PAN was the top-selling brand at ₹71 Cr. Ekta Batra shares more details. #Pharma #Growth #CNBCTV18Digital #SunPharma #Glenmark #Alkem